Tsukuba, Japan

Hideaki Imamura

This inventor holds 1 USPTO granted patent. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideaki Imamura. Retrieved from https://idiyas.com/inventor/hideaki-imamura-js1luxqv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hideaki Imamura

Introduction

Hideaki Imamura is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. His work has led to the creation of a patent that showcases his innovative approach to drug design.

Latest Patents

Imamura holds a patent for carbapenem derivatives, which are compounds represented by a specific general formula. This patent highlights his expertise in creating effective pharmaceutical solutions that can address various medical needs. The patent is a testament to his dedication to advancing healthcare through innovation.

Career Highlights

Throughout his career, Imamura has been associated with Banyu Pharmaceutical Co. Ltd., where he has contributed to various research and development projects. His work has not only enhanced the company's portfolio but has also played a crucial role in the advancement of pharmaceutical sciences.

Collaborations

Imamura has collaborated with esteemed colleagues such as Susumu Nakagawa and Norikazu Otake. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in their field.

Conclusion

Hideaki Imamura's contributions to the pharmaceutical industry through his patent and collaborations underscore his role as a key innovator. His work continues to influence the development of new therapeutic agents, making a lasting impact on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…